Demcon ranks in the R&D Top 50 of 2025!

Every year, Technisch Weekblad (TW) publishes its R&D Top 50, highlighting the most innovative companies in the Netherlands. We’re proud to announce that Demcon has secured a 21st place this year!

Sustainability at Demcon: not a project, but a way of working

Last summer, we were visited by Douwe de Vries, a reporter from Overijssel Onderweg. Throughout the season, he toured several companies in the province to learn about their sustainable mobility policies. True to the theme, he cycled all the way from the provincial government building in Zwolle to our headquarters in Enschede. During his visit, he interviewed Emma van Geel (Manager Corporate Sustainability) and Mika Bakker (Communications Specialist). You can read the result below.

SORTED Team ontvangt JTF subsidie (1600w)

Demcon industrial systems Groningen joins groundbreaking circular textile project SORTED.

Today in Assen, provincial deputies Bennema (Groningen) and Meeuwissen (Drenthe), together with council member Rink from the municipality of Emmen, awarded a subsidy of €14,927,479.42 to the project SORTED, a consortium of fourteen partners led by the Sympany foundation. The grant was provided by the ‘Samenwerkingsverband Noord-Nederland’ and originates from the European Just Transition Fund (JTF), including €6 million in co-financing from the Ministry of Economic Affairs.

Amsterdam police officially receives first Demcon selection post

In a significant step towards fairer and more transparent checks, the Amsterdam police have officially received the first selection post from Demcon high-tech systems this week. This innovative technology ensures that random checks are truly random, helping to prevent ethnic profiling.

Annual creating shared value overview 2024

We are publishing our annual overview of our creating shared value (CSV) initiatives. We remain committed to embedding our CSV priorities into our daily work. By doing so, we aim to create solutions that address real societal challenges and make a positive impact on our communities and the world around us.

North Brabant province invests 4 million euros in further development of molten salt reactor

The province of North Brabant is investing nearly 4 million euros in the further development of a new generation of nuclear reactors. A consortium of the companies Thorizon, VDL Groep and DEMCON will work in Brabant in the coming years to develop and test crucial components for a molten salt reactor. This investment should lead to new market opportunities for Brabant's high-quality manufacturing industry.

TNO and Demcon explore new joint venture in optics

TNO and Demcon have announced plans for a new joint venture aimed at bringing advanced technology for deformable mirrors to the global market.

SEISMIC consortium secures €23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments

Curix, part of the Demcon group, today announced that the SEISMIC research consortium, coordinated by Philips, together with the Erasmus MC as academic lead, has been awarded funding from the Innovative Health Initiative (IHI) to transform neurosurgery through the seamless integration of minimally invasive surgical techniques and advanced imaging technologies. The EUR 23.5 million public funding will be complemented by EUR 14.9 million in in-kind contributions and additional resources from industry partners, supporting a five-year research and innovation program that also includes eight clinical studies.

Demcon bolstered with the electronics expertise of Leap Development

Technology developer and producer Demcon further expands its technological capabilities with the introduction of Leap Development into the Demcon group. The company will continue its activities under the banner of Demcon electronics. The Deventer-based organization specializes in RF technology, wireless communication, embedded systems and integrated electronics development. With this latest addition, the Demcon group now has a specialized company that is dedicated entirely to electronics development projects and has state-of-the-art testing facilities.

Groundbreaking technology for the treatment of neurological diseases

Curix, part of the Demcon group, is developing groundbreaking technology for the treatment of life-threatening and debilitating neurological diseases. This new technology makes it possible to temporarily open the blood-brain barrier, addressing one of the biggest challenges in neurology. With this technology, drugs for brain tumors and neurodegenerative conditions, such as Alzheimer's and Parkinson's disease, can be delivered more efficiently. The participation of Twinning Participaties allows Curix to develop an injector system suitable for initial clinical studies in humans. “Our ultimate goal is to contribute to the development of improved treatments for neurological diseases”, says Peter Frinking, managing director and chief scientific officer at Curix.

View all items

events

meet us.

We are happy to share our knowledge of technology and our experiences with innovations during events throughout the year. We are also always looking for new ideas, partners and talents. We would love to meet you!

July 25, 2026—July 29, 2026

news.